Transgender "women" using hormone therapy are MORE likely to develop breast cancer

(Natural News) According to transgender dogma, using hormone therapy to try to switch genders is a completely safe, harmless and necessary line of treatment. But recently published research once again confirms that political agendas have no business in a medical setting. According to the latest research, trans women who undergo hormone therapy as part of...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news

Related Links:

Conclusions: Within our cohort, 66% had no documentation of counseling about menopausal symptoms before surgical menopause. Most women experienced symptoms postoperatively, but less than one-third of symptomatic women received hormone therapy. We have an opportunity to improve anticipatory guidance and informed consent for women undergoing surgical menopause.
Source: Menopause - Category: OBGYN Tags: Original Studies Source Type: research
In this study, an examination of the genomic distribution of histone modification and expression changes in two breast epithelial cell lines, the normal MCF10A cell line and the MCF-7 breast cancer cell line, upon treatment with several of the current therapies used for treating post-menopausal symptoms is presented. Analysis of the observed changes upon treatment with either 17 -estradiol (E2), a combined treatment with the top 10 most abundant Premarin chemical equivalents (EC10), the non-steroidal SERM, Bazadoxifene (BZA) and the TSEC; BZA combined with EC10 (Duavee) or BZA combined with E2 provides evidence of expre...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Homo sapiens Source Type: research
In this study, an examination of the genomic distribution of histone modification and expression changes in two breast epithelial cell lines, the normal MCF10A cell line and the MCF-7 breast cancer cell line, upon treatment with several of the current therapies used for treating post-menopausal symptoms is presented. Analysis of the observed changes upon treatment with either 17 -estradiol (E2), a combined treatment with the top 10 most abundant Premarin chemical equivalents (EC10), the non-steroidal SERM, Bazadoxifene (BZA) and the TSEC; BZA combined with EC10 (Duavee) or BZA combined with E2 provides evidence of expre...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Genome binding/occupancy profiling by high throughput sequencing Homo sapiens Source Type: research
CONCLUSION: The female predominance of diseases of the thyroid and breast makes difficult the separation of an expected association with a casual linkageThe relationship between the co-occurrence of breast and thyroid cancer remains controversial and inconclusive. KEY WORDS: Breast cancer, Breast surgery, Hormone therapy, Thyroid cancer, Thyroidectomy. PMID: 32719185 [PubMed - in process]
Source: Annali Italiani di Chirurgia - Category: Surgery Tags: Ann Ital Chir Source Type: research
No abstract available
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: View points Source Type: research
Editor's Summary by Mary McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the July 28, 2020 issue
Source: JAMA: This Week's Audio Commentary - Category: General Medicine Authors: Source Type: podcasts
This study reports 20-year breast cancer incidence among participants in Women ’s Health Initiative (WHI) trials randomized to conjugated equine estrogen (CEE) alone or with medroxyprogesterone acetate vs placebo.
Source: JAMA - Category: General Medicine Source Type: research
Reports from the Women ’s Health Initiative (WHI), first published in 2002, have informed and complicated the narrative of the relative benefits and potential harms of menopausal hormone therapy (HT) over the past 20 years. Prior to the initiation of the WHI trials, hormone therapy had already experienced a tumultuous p ublic stature. Initially heralded as the cure for menopause in the 1960s, unopposed estrogen therapy was vilified when its association with increased risk of endometrial hyperplasia and cancer emerged. The discovery that the addition of progesterone to estrogen therapy mitigated this risk propelled ho...
Source: JAMA - Category: General Medicine Source Type: research
(University of Southern California) A USC-led team of scientists has found that a fasting-mimicking diet combined with hormone therapy has the potential to help treat breast cancer, according to newly published animal studies and small clinical trials in humans.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Several decades ago, the concept of deintensification of breast cancer treatment began with randomized trials demonstrating breast conservation therapy (BCT) was equivalent to mastectomy with respect to recurrence and survival and optimized functional outcomes and quality of life. Radiation therapy (RT) has remained a mainstay of BCT, traditionally defined as lumpectomy followed by adjuvant RT and hormone therapy (in estrogen receptor –positive patients). The rationale for incorporating adjuvant radiation is the ability to eliminate microscopic disease after lumpectomy that could otherwise manifest as a local recurre...
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Clinical Investigation Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | Hormonal Therapy | Hormones | Politics | Women